[go: up one dir, main page]

CN111235239A - Multiple PCR _ SNP genotyping detection method - Google Patents

Multiple PCR _ SNP genotyping detection method Download PDF

Info

Publication number
CN111235239A
CN111235239A CN202010191848.2A CN202010191848A CN111235239A CN 111235239 A CN111235239 A CN 111235239A CN 202010191848 A CN202010191848 A CN 202010191848A CN 111235239 A CN111235239 A CN 111235239A
Authority
CN
China
Prior art keywords
pcr
detection method
snp genotyping
genotyping detection
snp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010191848.2A
Other languages
Chinese (zh)
Inventor
陈丹青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Women's Hospital, School of Medicine, Zhejiang University
Original Assignee
Women's Hospital, School of Medicine, Zhejiang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Women's Hospital, School of Medicine, Zhejiang University filed Critical Women's Hospital, School of Medicine, Zhejiang University
Priority to CN202010191848.2A priority Critical patent/CN111235239A/en
Publication of CN111235239A publication Critical patent/CN111235239A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明属于基因分型检测技术领域,公开了一种多重PCR_SNP基因分型检测方法,所述多重PCR_SNP基因分型检测方法包括:引物设计;组织、细胞及血样DNA提取;PCR扩增;PCR产物纯化;单碱基延伸;树脂纯化:每个延伸反应产物用6mg Clean Resin树脂纯化;芯片点样及质谱检测。本发明提供的多重PCR_SNP基因分型检测方法表明,在65个分型位点中,无信息量及分型成功率小于95%的位点为6个,占9.23%;MAF偏低SNP位点为6个,占9.23%;HWE检验p<1e‑2的SNP位点为7个,占10.77%;最终所用的有效SNP位点为59个,占90.77%。

Figure 202010191848

The invention belongs to the technical field of genotyping detection, and discloses a multiplex PCR_SNP genotyping detection method. The multiplex PCR_SNP genotyping detection method includes: primer design; DNA extraction from tissue, cells and blood samples; PCR amplification; PCR product Purification; single base extension; resin purification: each extension reaction product was purified with 6 mg of Clean Resin resin; chip spotting and mass spectrometry detection. The multiplex PCR_SNP genotyping detection method provided by the present invention shows that among the 65 typing sites, there are 6 sites with no information and a typing success rate of less than 95%, accounting for 9.23%; the MAF is relatively low SNP sites There were 6 SNP sites, accounting for 9.23%; HWE test p<1e‑2 SNP sites were 7, accounting for 10.77%; the final effective SNP sites used were 59, accounting for 90.77%.

Figure 202010191848

Description

一种多重PCR_SNP基因分型检测方法A kind of multiplex PCR_SNP genotyping detection method

技术领域technical field

本发明属于基因分型检测技术领域,尤其涉及一种多重PCR_SNP基因分型检测方法。The invention belongs to the technical field of genotyping detection, and in particular relates to a multiplex PCR_SNP genotyping detection method.

背景技术Background technique

目前,最接近的现有技术:聚合酶链式反应(PolymeraseChainReaction,PCR)的顺利进行是以模板单链与引物链按照碱基配对原则正确配对为前提。所以,在包含碱基差异的区域,设计一组只有单碱基差异的PCR引物,利用常见的PCR扩增仪,进行扩增,检测是否有符合设计片段长度的扩增产物产生,可以判断目标区域靶位点的碱基类型。但在使用常规PCR引物时,即使存在单碱基的错配,PCR反应有时也可以正常进行,得到与目的片段长度相同的扩增产物。因而使用常规引物进行PCR扩增分型时,无法排除假阳性结果,进而可能会得到错误的基因型分型结果。At present, the closest prior art: polymerase chain reaction (Polymerase Chain Reaction, PCR) is based on the premise that the template single strand and the primer strand are correctly paired according to the base pairing principle. Therefore, in the area containing base differences, design a set of PCR primers with only a single base difference, use a common PCR amplifier to amplify, and detect whether an amplification product that meets the designed fragment length is produced, and the target can be judged. The base type of the target site of the region. However, when using conventional PCR primers, even if there is a single base mismatch, the PCR reaction can sometimes proceed normally, and an amplification product with the same length as the target fragment can be obtained. Therefore, when using conventional primers for PCR amplification typing, false positive results cannot be excluded, and wrong genotyping results may be obtained.

目前,常用的SNP位点基因型检测方法主要有测序法、芯片法以及质谱法等,其中测序法价格比较昂贵,而芯片法和质谱法只有在同时测定多个位点或研究大群体样品时较有优势,且这三种方法都必须以相关的大型仪器平台作为支撑,存在多种局限。因此,亟需一种新的多重PCR_SNP基因分型检测方法,以弥补现有技术缺陷。At present, the commonly used methods for genotype detection of SNP loci mainly include sequencing method, chip method and mass spectrometry method, among which sequencing method is relatively expensive, while chip method and mass spectrometry method are only used for simultaneous determination of multiple loci or when studying large groups of samples. It has many advantages, and all three methods must be supported by the relevant large-scale instrument platform, and there are many limitations. Therefore, a new multiplex PCR_SNP genotyping detection method is urgently needed to make up for the deficiencies of the prior art.

综上所述,现有技术存在的问题是:现有SNP位点基因型检测方法中,测序法价格比较昂贵,而芯片法和质谱法只有在同时测定多个位点或研究大群体样品时较有优势,且这三种方法都必须以相关的大型仪器平台作为支撑,存在多种局限。To sum up, the problems existing in the prior art are: among the existing SNP locus genotype detection methods, the sequencing method is relatively expensive, while the chip method and mass spectrometry method can only be used to simultaneously measure multiple loci or study large population samples. It has many advantages, and all three methods must be supported by the relevant large-scale instrument platform, and there are many limitations.

发明内容SUMMARY OF THE INVENTION

针对现有技术存在的问题,本发明提供了一种多重PCR_SNP基因分型检测方法。Aiming at the problems existing in the prior art, the present invention provides a multiplex PCR_SNP genotyping detection method.

本发明是这样实现的,一种多重PCR_SNP基因分型检测方法,所述多重PCR_SNP基因分型检测方法PCR扩增时,引物的3`端碱基跟模板完全匹配时,DNA聚合酶进行延伸反应,检测信号就强;如果引物的3`端碱基跟模板不匹配,检测信号就弱;根据等位基因的基因型的不同设计不同的引物,将不同的等位基因区分开,在不同等位基因的引物5端各自连上一段不同的tag序列,序列能与芯片上点制的tag序列杂交,实现对基因型的判读。The present invention is achieved in this way, a multiple PCR_SNP genotyping detection method, when the multiple PCR_SNP genotyping detection method PCR amplification, when the 3'-end base of the primer is completely matched with the template, the DNA polymerase carries out an extension reaction , the detection signal is strong; if the bases at the 3' end of the primer do not match the template, the detection signal is weak; design different primers according to the genotype of the allele to distinguish different alleles. The 5 ends of the primers of the allele are respectively connected with a different tag sequence, and the sequence can hybridize with the tag sequence ordered on the chip to realize the interpretation of the genotype.

进一步,所述多重PCR_SNP基因分型检测方法的四个SNP位点设计引物,并在上游引物的5`端分别连接Tag1/Tag2、Tag3/Tag4、Tag5/Tag6、Tag7/Tag8,同时用这四对Tag点制芯片,每个Tag重复点3个点,同时点上杂交阳性质控点PC 3个,杂交阴性质控点NC 3个,Blank点3个,Hex点3个。Further, the four SNP sites of the multiplex PCR_SNP genotyping detection method design primers, and connect Tag1/Tag2, Tag3/Tag4, Tag5/Tag6, Tag7/Tag8 at the 5' ends of the upstream primers, and simultaneously use these four For Tag spotting, 3 spots were repeated for each Tag, and 3 hybridization positive quality control spots PC, 3 hybridization negative quality control spots NC, 3 Blank spots, and 3 Hex spots were spotted at the same time.

进一步,所述多重PCR_SNP基因分型检测方法包括设计待测SNP位点的PCR扩增引物及单碱基延伸引物。Further, the multiplex PCR_SNP genotyping detection method includes designing PCR amplification primers and single-base extension primers for the SNP sites to be detected.

进一步,所述多重PCR_SNP基因分型检测方法包括提取血样中的DNA,用分光光度计定量,琼脂糖凝胶电泳质检,质检合格的DNA将浓度调整到50ηg/ul,-20℃储存备用。Further, the multiplex PCR_SNP genotyping detection method includes extracting DNA in the blood sample, quantifying with a spectrophotometer, performing quality inspection on agarose gel electrophoresis, adjusting the concentration of qualified DNA to 50ηg/ul, and storing at -20°C for later use. .

进一步,所述多重PCR_SNP基因分型检测方法包括PCR扩增,采用多重PCR扩增技术,每个反应总体积5ul,包含模板DNA 10ηg,Hotstar Taq 0.5U,扩增引物每条0.5pmol,25mM dNTP,0.1ul,反应条件为94℃4分钟;94℃20秒,56℃30秒,72℃1分钟,45个循环;72℃3分钟;4℃。Further, the multiplex PCR_SNP genotyping detection method comprises PCR amplification, using multiplex PCR amplification technology, the total volume of each reaction is 5ul, including template DNA 10ng, Hotstar Taq 0.5U, each amplification primer 0.5pmol, 25mM dNTPs , 0.1ul, the reaction conditions are 94 ℃ for 4 minutes; 94 ℃ for 20 seconds, 56 ℃ for 30 seconds, 72 ℃ for 1 minute, 45 cycles; 72 ℃ for 3 minutes; 4 ℃.

进一步,所述多重PCR_SNP基因分型检测方法包括PCR产物纯化,PCR反应产物使用0.5U SAP处理,去除体系中游离的dNTP,反应体系7μl,其中PCR产物5μl,SAP混合液2μl,SAP0.5U,buffer 0.17μl,反应程序37℃20分钟;85℃5分钟;4℃。Further, the multiplex PCR_SNP genotyping detection method includes the purification of PCR products, the PCR reaction products are treated with 0.5U SAP, the free dNTPs in the system are removed, and the reaction system is 7 μl, wherein the PCR product is 5 μl, the SAP mixture is 2 μl, and the SAP is 0.5U, buffer 0.17μl, the reaction program is 37°C for 20 minutes; 85°C for 5 minutes; 4°C.

进一步,所述多重PCR_SNP基因分型检测方法包括单碱基延伸,总体积9μl反应体系包含SAP处理后PCR产物7μl,其中各延伸反应引物混合物0.804l,iPLEX酶0.041l,延伸混合物0.2μl。反应程序为94℃30秒;94℃5秒;52℃5秒,80℃5秒5个循环;返回94℃5秒,共40个循环;72℃3分钟,4℃。Further, the multiplex PCR_SNP genotyping detection method includes single base extension, the total volume of 9 μl reaction system contains 7 μl of PCR product after SAP treatment, wherein each extension reaction primer mixture is 0.804l, iPLEX enzyme is 0.041l, and extension mixture is 0.2μl. The reaction program was 94°C for 30 seconds; 94°C for 5 seconds; 52°C for 5 seconds, 80°C for 5 seconds for 5 cycles; return to 94°C for 5 seconds, a total of 40 cycles; 72°C for 3 minutes, 4°C.

进一步,所述多重PCR_SNP基因分型检测方法包括树脂纯化,每个延伸反应产物用6mg Clean Resin树脂纯化;Further, the multiplex PCR_SNP genotyping detection method comprises resin purification, and each extension reaction product is purified with 6mg Clean Resin resin;

芯片点样及质谱检测,将纯化产物移至384孔SpectroCHIP芯片上,上机测定。SpectroCHIP芯片使用MALDI-TOF基质辅助激光解吸附电离飞行时间质谱分析,检测结果使用软件分型并输出结果。After chip spotting and mass spectrometry detection, the purified product was transferred to a 384-well SpectroCHIP chip and measured on the machine. SpectroCHIP chip uses MALDI-TOF matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis, and the detection results are typed and output by software.

进一步,所述多重PCR_SNP基因分型检测方法包括Further, the multiplex PCR_SNP genotyping detection method includes

(1)数据预处理,过滤掉在所有样品中无信息量的位点及分型成功率小于90%的位点;过滤掉在对照样品中MAF小于0.01的位点;用对照样品,对每个SNP位点进行哈迪-温伯格平衡检验;(1) Data preprocessing, filtering out non-informative sites in all samples and sites with typing success rate less than 90%; filtering out sites with MAF less than 0.01 in control samples; using control samples, for each Hardy-Weinberg equilibrium test for each SNP site;

(2)单点关联分析方法,针对预处理后的每个位点,用卡方检验和Fisher精确检验方法对四种情况检验病例和对照间的差异,并对能计算比值比的情况,计算比值比及其95%置信区间。(2) Single-point association analysis method, for each locus after preprocessing, the chi-square test and Fisher's exact test were used to test the differences between the cases and controls for the four cases, and for the cases where the odds ratio could be calculated, calculate Odds ratios and their 95% confidence intervals.

进一步,所述多重PCR_SNP基因分型检测方法包括四种情况:Further, the multiplex PCR_SNP genotyping detection method includes four situations:

(1)对等位基因频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间;(1) Perform chi-square test and Fisher exact test on allele frequencies and calculate OR value and 95% confidence interval;

(2)对基因型频率进行卡方检验和Fisher精确检验;(2) Chi-square test and Fisher's exact test for genotype frequencies;

(3)针对显性模型对基因型频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间;(3) Chi-square test and Fisher's exact test were performed on the genotype frequencies for the dominant model, and the OR value and 95% confidence interval were calculated;

(4)针对隐性模型对基因型频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间。(4) Chi-square test and Fisher's exact test were performed on the genotype frequencies for the recessive model, and the OR value and 95% confidence interval were calculated.

综上所述,本发明的优点及积极效果为:本发明提供的多重PCR_SNP基因分型检测方法,实验表明,在65个分型位点中,无信息量及分型成功率(call rate)小于95%的位点为6个(占9.23%),MAF偏低SNP位点为6个(占9.23%),HWE检验p<1e-2的SNP位点为7(占10.77%),最终所用的有效SNP位点为59(占90.77%)。对预处理后的每个位点进行关联分析。将Fisher精确检验的p值小于0.05的4个显著位点挑出,并结合这些位点的哈迪-温伯格平衡检验结果及分型质量对其进行综合评分,最高分为5,最低分为1。To sum up, the advantages and positive effects of the present invention are as follows: in the multiplex PCR_SNP genotyping detection method provided by the present invention, experiments show that in the 65 typing loci, there is no information amount and typing success rate (call rate). There are 6 sites with less than 95% (9.23%), 6 SNP sites with low MAF (9.23%), and 7 SNP sites with p<1e-2 by HWE test (10.77%). The effective SNP site used was 59 (90.77%). Association analysis was performed for each locus after preprocessing. Four significant loci with a Fisher's exact test p value less than 0.05 were selected, and combined with the Hardy-Weinberg balance test results and typing quality of these loci to give a comprehensive score, the highest score was 5, and the lowest score was 5. is 1.

附图说明Description of drawings

图1是本发明实施例提供的多重PCR_SNP基因分型检测方法流程图。FIG. 1 is a flowchart of a multiplex PCR_SNP genotyping detection method provided in an embodiment of the present invention.

图2是本发明实施例1提供的多重PCR_SNP基因分型检测原理图。FIG. 2 is a schematic diagram of the multiplex PCR_SNP genotyping detection principle provided in Example 1 of the present invention.

图3是本发明实施例1提供的多重PCR_SNP基因分型检测实验设计图。FIG. 3 is a diagram of the experimental design of the multiplex PCR_SNP genotyping detection provided in Example 1 of the present invention.

图4-图6是本发明实施例1提供的多重PCR_SNP基因分型检测实验结果图。4-6 are graphs of the results of the multiplex PCR_SNP genotyping detection experiment provided in Example 1 of the present invention.

图7是本发明实施例2提供的PCR-SNP测序方法流程图。7 is a flow chart of the PCR-SNP sequencing method provided in Example 2 of the present invention.

图8是本发明实施例2提供的琼脂糖凝胶电泳质控结果示意图(方案A-90C)。8 is a schematic diagram of the quality control results of agarose gel electrophoresis provided in Example 2 of the present invention (scheme A-90C).

图9是本发明实施例2提供的琼脂糖凝胶电泳质控结果示意图(方案B-3C)。9 is a schematic diagram of the quality control results of agarose gel electrophoresis provided in Example 2 of the present invention (scheme B-3C).

图10是本发明实施例2提供的荧光定量PCR质控结果示意图(方案A-90C)。Figure 10 is a schematic diagram of the quality control results of fluorescence quantitative PCR provided in Example 2 of the present invention (scheme A-90C).

图11是本发明实施例2提供的荧光定量PCR质控结果示意图(方案B-3C)。Figure 11 is a schematic diagram of the quality control results of fluorescence quantitative PCR provided in Example 2 of the present invention (scheme B-3C).

具体实施方式Detailed ways

为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.

针对现有技术存在的问题,本发明提供了一种多重PCR_SNP基因分型检测方法,下面结合附图对本发明作详细的描述。In view of the problems existing in the prior art, the present invention provides a multiplex PCR_SNP genotyping detection method. The present invention will be described in detail below with reference to the accompanying drawings.

如图1所示,本发明实施例提供的多重PCR_SNP基因分型检测方法包括以下步骤:As shown in Figure 1, the multiplex PCR_SNP genotyping detection method provided in the embodiment of the present invention comprises the following steps:

S101:引物设计。S101: Primer design.

S102:组织、细胞及血样DNA提取。S102: DNA extraction from tissues, cells and blood samples.

S103:PCR扩增。S103: PCR amplification.

S104:PCR产物纯化。S104: PCR product purification.

S105:单碱基延伸。S105: Single base extension.

S106:树脂纯化:每个延伸反应产物用6mg Clean Resin树脂纯化。S106: Resin purification: Each extension reaction product was purified with 6 mg of Clean Resin resin.

S107:芯片点样及质谱检测。S107: Chip spotting and mass spectrometry detection.

下面结合实施例对本发明的技术方案作进一步的描述。The technical solutions of the present invention will be further described below in conjunction with the embodiments.

实施例1:多重PCR_SNP基因分型检测实验Embodiment 1: Multiplex PCR_SNP genotyping detection experiment

1、材料1. Materials

取临床就诊130例孕妇血样,其中正常79例,糖尿病人51例,每份样本准备2ml全血,抽血后马上加入EDTA抗凝管(美国BD公司),马上颠倒混匀,-20℃冰箱中保存。Blood samples were taken from 130 pregnant women, including 79 normal patients and 51 diabetic patients. 2ml of whole blood was prepared for each sample. Immediately after the blood was drawn, an EDTA anticoagulation tube (BD Company, USA) was added, and it was immediately inverted and mixed. save in.

2、方法2. Method

2.1芯片实验原理2.1 The principle of chip experiment

如图2所示,通用芯片技术原理是:PCR扩增时,引物的3`端碱基跟模板完全匹配时,DNA聚合酶才能有效地进行延伸反应,最终的检测信号就强;如果引物的3`端碱基跟模板不匹配,延伸效率就会大大降低,最终的检测信号就弱。根据等位基因的基因型的不同设计不同的引物,就可以将不同的等位基因区分开来。在不同等位基因的引物5端各自连上一段不同的tag序列,这些序列能与芯片上点制的tag序列杂交,从而实现对基因型的判读。As shown in Figure 2, the principle of general chip technology is: during PCR amplification, the DNA polymerase can effectively carry out the extension reaction when the 3'-end base of the primer is completely matched with the template, and the final detection signal is strong; If the base at the 3' end does not match the template, the extension efficiency will be greatly reduced, and the final detection signal will be weak. Different alleles can be distinguished by designing different primers according to the different genotypes of the alleles. A different tag sequence is connected to the 5 ends of the primers of different alleles, and these sequences can hybridize with the tag sequences spotted on the chip, so as to realize the interpretation of the genotype.

2.2实验设计2.2 Experimental Design

如图3所示,对前期实验挑出的四个SNP位点设计引物,并在上游引物的5`端分别连接Tag1/Tag2、Tag3/Tag4、Tag5/Tag6、Tag7/Tag8,同时用这四对Tag点制芯片,每个Tag重复点3个点,同时点上杂交阳性质控点(PC)3个,杂交阴性质控点(NC)3个,Blank点(1*的点样液)3个,Hex点3个。As shown in Figure 3, primers were designed for the four SNP sites selected in the previous experiment, and Tag1/Tag2, Tag3/Tag4, Tag5/Tag6, and Tag7/Tag8 were connected to the 5' ends of the upstream primers. For Tag spotting chip, 3 spots are repeated for each Tag, and 3 hybridization positive quality control spots (PC), 3 hybridization negative quality control spots (NC), and Blank spots (1* spotting solution) are spotted at the same time. 3, Hex points 3.

2.3芯片实验步骤2.3 Chip experiment steps

筛选文献报道和糖尿病有关的和70个SNP位点,经过前期引物设计,选取其中65个位点(附件2),使用Sequenom

Figure BDA0002416206000000061
分子量阵列技术(美国Sequenom公司),对130例样本的65个SNP位点进行分型,具体如下:Screened 70 SNP sites reported in literature and related to diabetes, after preliminary primer design, 65 of them were selected (Appendix 2), using Sequenom
Figure BDA0002416206000000061
Molecular weight array technology (Sequenom, USA) was used to type 65 SNP loci in 130 samples, as follows:

2.3.1引物设计2.3.1 Primer Design

使用Sequenom公司Genotyping Tools及MassARRAY Assay Design软件设计待测SNP位点的PCR扩增引物及单碱基延伸引物,引物由Initrogen公司北京合成部合成。Genotyping Tools and MassARRAY Assay Design software of Sequenom Company were used to design PCR amplification primers and single-base extension primers of the SNP site to be tested, and the primers were synthesized by Beijing Synthesis Department of Innitrogen Company.

2.3.2组织、细胞及血样DNA提取2.3.2 DNA extraction from tissues, cells and blood samples

使用Wizard Genomic DNA purification Kit(Promega)提取血样中的DNA,用分光光度计定量,琼脂糖凝胶电泳质检。质检合格的DNA将浓度调整到50ηg/ul,-20℃储存备用。DNA in blood samples was extracted using Wizard Genomic DNA purification Kit (Promega), quantified by spectrophotometer, and checked by agarose gel electrophoresis. The DNA that passed the quality inspection was adjusted to a concentration of 50ηg/ul and stored at -20°C for later use.

2.3.3PCR扩增2.3.3 PCR amplification

采用多重PCR扩增技术,每个反应总体积5ul,包含模板DNA 10ηg,,Hotstar Taq0.5U,扩增引物每条0.5pmol,25mM dNTP,0.1ul,反应条件为94℃4分钟;94℃20秒,56℃30秒,72℃1分钟,45个循环;72℃3分钟;4℃。Using multiplex PCR amplification technology, the total volume of each reaction is 5ul, including template DNA 10ηg, Hotstar Taq 0.5U, each amplification primer 0.5pmol, 25mM dNTP, 0.1ul, the reaction conditions are 94 °C for 4 minutes; 94 °C 20 seconds, 56°C for 30 seconds, 72°C for 1 minute, 45 cycles; 72°C for 3 minutes; 4°C.

2.3.4PCR产物纯化2.3.4 PCR product purification

PCR反应产物使用0.5U SAP(shrimp alkaline phosphatase)处理,去除体系中游离的dNTP。反应体系7μl,其中PCR产物5μl,SAP混合液2μl(SAP 0.5U,buffer 0.17μl)。反应程序37℃20分钟;85℃5分钟;4℃。The PCR reaction product was treated with 0.5U SAP (shrimp alkaline phosphatase) to remove free dNTPs in the system. The reaction system was 7 μl, including 5 μl of PCR product and 2 μl of SAP mixture (SAP 0.5U, buffer 0.17 μl). Reaction program 37°C for 20 minutes; 85°C for 5 minutes; 4°C.

2.3.5单碱基延伸2.3.5 Single base extension

总体积9μl反应体系包含SAP处理后PCR产物7μl,其中各延伸反应引物混合物0.804l,iPLEX酶0.041l,延伸混合物0.2μl。反应程序为94℃30秒;94℃5秒;52℃5秒,80℃5秒5个循环;返回94℃5秒,共40个循环;72℃3分钟,4℃。The total volume of the 9 μl reaction system contained 7 μl of the PCR product after SAP treatment, wherein each extension reaction primer mix was 0.804 l, iPLEX enzyme was 0.041 l, and the extension mixture was 0.2 μl. The reaction program was 94°C for 30 seconds; 94°C for 5 seconds; 52°C for 5 seconds, 80°C for 5 seconds for 5 cycles; return to 94°C for 5 seconds, a total of 40 cycles; 72°C for 3 minutes, 4°C.

2.3.6树脂纯化2.3.6 Resin purification

每个延伸反应产物用6mg Clean Resin树脂纯化。Each extension reaction product was purified with 6 mg of Clean Resin resin.

2.3.7芯片点样及质谱检测2.3.7 Chip spotting and mass spectrometry detection

将纯化产物移至384孔SpectroCHIP(Sequenom)芯片上,上机测定。SpectroCHIP芯片使用MALDI-TOF(matrix-assisted laser desorption/ionization–time offlight)基质辅助激光解吸附电离飞行时间质谱分析,检测结果使用TYPER 4.0软件(sequenom)分型并输出结果。The purified product was transferred to a 384-well SpectroCHIP (Sequenom) chip and measured on the machine. SpectroCHIP chip uses MALDI-TOF (matrix-assisted laser desorption/ionization-time offlight) matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis, and the detection results are typed and output using TYPER 4.0 software (sequenom).

3、关联分析方法3. Correlation analysis method

3.1数据预处理3.1 Data preprocessing

(1)过滤掉在所有样品中无信息量的位点及分型成功率(call rate)小于90%的位点;(1) Filter out sites with no information in all samples and sites with a call rate less than 90%;

(2)过滤掉在对照样品中MAF(minor allele frequency)小于0.01的位点;(2) filter out the sites with MAF (minor allele frequency) less than 0.01 in the control sample;

(3)用对照样品,对每个SNP位点进行哈迪-温伯格平衡(Hardy-WeinbergEquilibrium,HWE)检验。(3) Using the control sample, carry out Hardy-Weinberg Equilibrium (HWE) test for each SNP site.

3.2单点关联分析方法3.2 Single point correlation analysis method

针对预处理后的每个位点,用卡方检验和Fisher精确检验方法对四种情况检验病例和对照间的差异,并对能计算比值比(odds ratio,OR)的情况,计算比值比及其95%置信区间。For each locus after preprocessing, chi-square test and Fisher's exact test were used to test the differences between cases and controls for the four cases, and for the cases where the odds ratio (OR) could be calculated, calculate the odds ratio and Its 95% confidence interval.

四种情况如下:The four cases are as follows:

1.对等位基因频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间,具体数据形式如表1所示。1. Perform chi-square test and Fisher exact test on allele frequencies and calculate OR value and 95% confidence interval. The specific data form is shown in Table 1.

表1等位基因频率进行实验数据Table 1 Allele frequencies for experimental data

Figure BDA0002416206000000071
Figure BDA0002416206000000071

注:计算OR值时以B为参考Note: B is used as a reference when calculating the OR value

2.对基因型频率进行卡方检验和Fisher精确检验,具体数据形式如表2所示。2. Chi-square test and Fisher's exact test were performed on the genotype frequencies, and the specific data forms are shown in Table 2.

表2基因型频率进行实验数据Table 2 Genotype frequencies for experimental data

Figure BDA0002416206000000072
Figure BDA0002416206000000072

Figure BDA0002416206000000081
Figure BDA0002416206000000081

3.针对显性模型对基因型频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间,具体数据形式如表3所示。3. Perform chi-square test and Fisher's exact test on the genotype frequencies for the dominant model and calculate the OR value and 95% confidence interval. The specific data form is shown in Table 3.

表3显性模型对基因型频率进行实验数据Table 3. Experimental data on genotype frequency by dominant model

Figure BDA0002416206000000082
Figure BDA0002416206000000082

注:计算OR值时以BB为参考Note: BB is used as a reference when calculating the OR value

其中,AA为野生纯合基因型。Among them, AA is the wild homozygous genotype.

4.针对隐性模型对基因型频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间,具体数据形式如表4所示。4. Perform chi-square test and Fisher's exact test on the genotype frequencies for the recessive model and calculate the OR value and 95% confidence interval. The specific data form is shown in Table 4.

表4隐性模型对基因型频率进行实验数据Table 4. Experimental data of recessive model on genotype frequency

Figure BDA0002416206000000083
Figure BDA0002416206000000083

注:计算OR值时以BB+AB为referenceNote: BB+AB is the reference when calculating the OR value

其中,AA为野生纯合基因型。Among them, AA is the wild homozygous genotype.

5、结果5. Results

在65个分型位点中,无信息量及分型成功率(call rate)小于95%的位点为6个(占9.23%),MAF偏低SNP位点为6个(占9.23%),HWE检验p<1e-2的SNP位点为7(占10.77%),最终所用的有效SNP位点为59(占90.77%)。Among the 65 typing loci, there are 6 loci (9.23%) with no information and a call rate of less than 95%, and 6 SNP loci with low MAF (9.23%) , HWE test p<1e-2 SNP site is 7 (accounting for 10.77%), and the final effective SNP site used is 59 (accounting for 90.77%).

对预处理后的每个位点进行关联分析。将在上述四种情况下Fisher精确检验的p值小于0.05的4个显著位点挑出,并结合这些位点的哈迪-温伯格平衡检验结果及分型质量对其进行综合评分,最高分为5,最低分为1。4个显著位点情况表5所示。Association analysis was performed for each locus after preprocessing. Four significant loci with a Fisher's exact test p value less than 0.05 in the above four cases were selected, and combined with the Hardy-Weinberg equilibrium test results and typing quality of these loci to give a comprehensive score, the highest It is divided into 5 and the lowest score is 1. The 4 significant loci are shown in Table 5.

表5 4个显著位点情况Table 5 4 significant loci

Figure BDA0002416206000000084
Figure BDA0002416206000000084

Figure BDA0002416206000000091
Figure BDA0002416206000000091

(注:SNPname:SNP编号,HWE-pValue:HWE-pValue,SNP Call Rate:SNP的callrate值,Score:综合分数)。(Note: SNPname: SNP number, HWE-pValue: HWE-pValue, SNP Call Rate: SNP callrate value, Score: Comprehensive score).

如图4所示,用人工合成的与Tag序列互补的cTag与芯片杂交,可以检验芯片的质量。本实验用了Tag1、2、3、4、7、8的cTag序列及PC的互补序列与芯片杂交,可以看到各Tag点、PC点和HEX点信号都比较强,而NC点和BC点则没有信号,cTag5、cTag6没有加入,其对应的位点没有信号,证明芯片的质量没有问题。As shown in Figure 4, the quality of the chip can be checked by hybridizing the artificially synthesized cTag complementary to the Tag sequence with the chip. In this experiment, the cTag sequences of Tag1, 2, 3, 4, 7, and 8 and the complementary sequences of PC were used to hybridize with the chip. It can be seen that the signals of each Tag point, PC point and HEX point are relatively strong, while NC point and BC point have strong signals. Then there is no signal, cTag5 and cTag6 are not added, and there is no signal at the corresponding site, which proves that the quality of the chip is no problem.

如图5所示,四个位点的引物单独做PCR扩增,电泳显示的产物条带大小跟预期的一致。显示引物设计合成没有问题。As shown in Figure 5, the primers of the four sites were individually amplified by PCR, and the size of the product bands displayed by electrophoresis was consistent with the expected. It is shown that the primer design and synthesis are no problem.

如图6所示,取糖尿病和正常个体各两个样本,进行四重PCR扩增后分别与芯片杂交,对照Sequenom的实验结果,红框的位置为预期的信号比较强阳性点,蓝框的位置是预期的信号比较弱的阴性点,白框为质控点。从实验结果看,四个位点中,预期的阳性点信号都比较好,其中三个SNP位点阳性点的信号高于阴性点信号。但位点2阴性点信号和阳性点信号一样强。四个位点有三个表现良好,可以用阳性点和阴性点信号值得比值来判断基因型。As shown in Figure 6, two samples from diabetic individuals and two samples from normal individuals were taken and hybridized with the chip after quadruple PCR amplification. Compared with the experimental results of Sequenom, the position of the red box is the expected strong positive point, and the blue box The position is the expected negative point with relatively weak signal, and the white box is the quality control point. From the experimental results, among the four sites, the expected signals of positive sites are all better, and the signals of positive sites of three SNP sites are higher than those of negative sites. But the signal of site 2 negative point is as strong as that of positive point. Three of the four loci performed well, and the genotype could be judged by the ratio of the signal values of the positive and negative loci.

实施例2:PCR-SNP测序实验Example 2: PCR-SNP sequencing experiment

1、项目流程1. Project process

项目主要流程如图7所示,目标区域重测序结合多重PCR技术和高通量测序技术,对需要检测的位点设计特异性引物,在单管内进行多重PCR扩增,不同的样本以不同的Barcode引物区分,对扩增子进行高通量测序。测序结果使用生物信息学方法,区分不同的样本,最终获得每个位点的突变信息。The main process of the project is shown in Figure 7. The target region resequencing combines multiple PCR technology and high-throughput sequencing technology to design specific primers for the sites to be detected, and perform multiple PCR amplification in a single tube. Barcode primers differentiate and perform high-throughput sequencing of the amplicons. The sequencing results use bioinformatics methods to distinguish different samples and finally obtain mutation information for each locus.

2、材料与方法2. Materials and methods

2.1实验材料2.1 Experimental materials

2.1.1实验仪器2.1.1 Experimental instrument

主要实验仪器及生产厂家如表6所示。The main experimental instruments and manufacturers are shown in Table 6.

表6主要实验仪器及生产厂家Table 6 Main experimental instruments and manufacturers

Figure BDA0002416206000000101
Figure BDA0002416206000000101

2.1.2实验试剂2.1.2 Experimental reagents

主要实验试剂、耗材及生产厂家如表7所示。The main experimental reagents, consumables and manufacturers are shown in Table 7.

表7主要实验试剂、耗材及生产厂家Table 7 Main experimental reagents, consumables and manufacturers

Figure BDA0002416206000000102
Figure BDA0002416206000000102

2.1.3软件与网络资源2.1.3 Software and Network Resources

主要实验软件与网络资源如表8所示。The main experimental software and network resources are shown in Table 8.

表8主要实验软件与网络资源Table 8 Main experimental software and network resources

Figure BDA0002416206000000103
Figure BDA0002416206000000103

2.2实验方法2.2 Experimental method

2.2.1目的基因引物序列2.2.1 Target gene primer sequences

2.2.2文库制备2.2.2 Library preparation

2.2.2.1多重PCR的引物调整2.2.2.1 Primer adjustment for multiplex PCR

1.一轮PCR1. One round of PCR

以多重引物工作液对质控品及N丁C进行首轮扩增。扩增体系及反应条件如表9所示,PCR程序如表10所示。The first round of amplification was performed on the quality control product and Nbutin C with the multiple primer working solution. The amplification system and reaction conditions are shown in Table 9, and the PCR program is shown in Table 10.

表9扩增体系Table 9 Amplification system

Figure BDA0002416206000000111
Figure BDA0002416206000000111

表10 PCR程序Table 10 PCR program

Figure BDA0002416206000000112
Figure BDA0002416206000000112

2.二轮PC R2. Two rounds of PCR

一轮产物每孔加dd日20100u1,瞬时离心,室温静置lOmin。以稀释液作为二轮扩增模板,扩增体系及反应条件如表11所示,PCR程序如表12所示。Add 20100u1 dd day to each well of one round product, centrifuge briefly, and let stand for 10min at room temperature. The diluent was used as the second round of amplification template, the amplification system and reaction conditions were shown in Table 11, and the PCR program was shown in Table 12.

表11扩增体系Table 11 Amplification system

Figure BDA0002416206000000113
Figure BDA0002416206000000113

表12 PCR程序Table 12 PCR program

Figure BDA0002416206000000121
Figure BDA0002416206000000121

3.扩增结束后,将PCR产物进行电泳检测,3%琼脂糖凝胶,PCR产物上样5u1,观察电泳条带是否均一,是否有杂带等。3. After the amplification, the PCR product was subjected to electrophoresis detection, 3% agarose gel, and the PCR product was loaded with 5u1 to observe whether the electrophoresis bands were uniform and whether there were any miscellaneous bands.

4.根据多重PCR的重数确定稀释小试样本数(一次384板检测极限)。将小试样本稀释至10-4进行qPCR检测。实验结束后,根据Ct值调整初始的多重引物mix。qPCR扩增体系如表13所示,qPCR程序如表14所示。4. Determine the number of diluted aliquots according to the multiplex of multiplex PCR (detection limit of 384 plates at a time). A small sample was diluted to 10-4 for qPCR detection. After the experiment, adjust the initial multiplex primer mix according to the Ct value. The qPCR amplification system is shown in Table 13, and the qPCR program is shown in Table 14.

表13 qPCR扩增体系Table 13 qPCR amplification system

Figure BDA0002416206000000122
Figure BDA0002416206000000122

表14 qPCR程序Table 14 qPCR program

Figure BDA0002416206000000123
Figure BDA0002416206000000123

2.2.2.2产物生产2.2.2.2 Product production

1.一轮PCR1. One round of PCR

取调整好的多重弓l物工作液配制PCR mix,分装于与所需数量相对应的96孔板中。取样本板充分解冻、震荡,1000rpm离心is后进行加样。加样时每板预留2个孔,分别加入阳性及阴性对照。一轮扩增体系如表15所示,PCR程序如表16所示。Take the adjusted polyplex working solution to prepare PCR mix, and distribute it in 96-well plates corresponding to the required number. Take the sample plate and fully thaw it, shake it, centrifuge it at 1000rpm, and then add the sample. When adding samples, 2 wells were reserved in each plate, and positive and negative controls were added respectively. The one-round amplification system is shown in Table 15, and the PCR program is shown in Table 16.

表15 PCR扩增体系Table 15 PCR amplification system

Figure BDA0002416206000000131
Figure BDA0002416206000000131

表16 PCR程序Table 16 PCR program

Figure BDA0002416206000000132
Figure BDA0002416206000000132

2.二轮PC R2. Two rounds of PCR

一轮产物每孔加ddH2O 100u1,瞬时离心,室温静置l0min。以稀释液作为二轮扩增模板,扩增体系如表17所示,PCR程序如表18所示。Add 100u1 of ddH 2 O to each well of one round of products, centrifuge briefly, and let stand at room temperature for 10 min. The diluent was used as the template for the second round of amplification, the amplification system was shown in Table 17, and the PCR program was shown in Table 18.

表17 PCR扩增体系Table 17 PCR amplification system

Figure BDA0002416206000000133
Figure BDA0002416206000000133

表18 PCR程序Table 18 PCR program

Figure BDA0002416206000000134
Figure BDA0002416206000000134

3.扩增结束后,将PCR产物进行电泳检测,3%琼脂糖凝胶,PCR产物上样5ul,观察电泳条带是否均一,是否有杂带等。3. After the amplification, the PCR product is subjected to electrophoresis detection, 3% agarose gel, and 5 ul of the PCR product is loaded to observe whether the electrophoresis bands are uniform and whether there are any miscellaneous bands.

2.2.2.3文库混样2.2.2.3 Library Mixing

1.取96孔板1块。调排枪至5ul,插取Axygen 10ul枪头,PCR板每孔吸取5ul产物转移至U型槽中,转移产物时应慢速吸取,保证无漏吸枪头。1. Take one 96-well plate. Adjust the gun to 5ul, insert the Axygen 10ul pipette tip, and transfer 5ul of the product to each well of the PCR plate and transfer it to the U-shaped groove.

2.取圆底离心管1支,将管盖拧下,以封口膜缠绕圆底离心管的螺旋口2周备用,注意缠绕时为顺时针方向。2. Take 1 round-bottom centrifuge tube, unscrew the cap, and wrap the spiral mouth of the round-bottom centrifuge tube with parafilm for 2 circles for later use. Note that the winding is clockwise.

3.取200ul移液枪,插取Axygen枪头将U型槽中的产物mix转移至圆底离心管中。3. Take a 200ul pipette, insert the Axygen tip, and transfer the product mix in the U-shaped groove to a round-bottomed centrifuge tube.

4.拧紧管盖,涡旋震荡30秒。4. Tighten the cap and vortex for 30 seconds.

5.将离心管平行固定在摇床上,启动摇床,观察管中液体移动状态,调整摇床至适合的速度,以管中液体振幅最大为宜,将产物mix震荡过夜。5. Fix the centrifuge tube on the shaker in parallel, start the shaker, observe the movement of the liquid in the tube, adjust the shaker to a suitable speed, and the maximum liquid amplitude in the tube is appropriate, and shake the product mix overnight.

2.2.2.4纯化2.2.2.4 Purification

1.将混样后的文库上样电泳,电泳完毕后,割取目标片段,将片段切碎,分为4份置于4个1.5ml低吸附EP管中。将内置凝胶的印管称重,减去管重,计算凝胶质量并记录于管盖。向胶块中加入等倍体积溶液PN(如果凝胶重为0.1g,其体积可视为100ul,则加入100ulPN溶液),50℃水浴放置,其间不断温和地上下翻转离心管,以确保胶块充分溶解。如果还有未溶的胶块,可继续放置几分钟或再补加一些溶胶液,直至胶块完全溶解。1. Load the mixed library into electrophoresis. After electrophoresis, cut out the target fragments, chop the fragments, divide them into 4 parts and place them in 4 1.5ml low adsorption EP tubes. The printed tube containing the gel was weighed, the tube weight was subtracted, and the gel mass was calculated and recorded on the tube cap. Add an equal volume of solution PN to the gel block (if the gel weight is 0.1g, and its volume can be regarded as 100ul, then add 100ul of PN solution), place it in a water bath at 50°C, and gently turn the centrifuge tube up and down to ensure the gel block. Fully dissolved. If there are still undissolved glue pieces, you can continue to stand for a few minutes or add some more sol solution until the glue pieces are completely dissolved.

2.凝胶溶解时,取4个吸附柱放入收集管中,向吸附柱中加入500ul平衡液BL,12000rpm离心1min,倒掉收集管中的废液,将吸附柱重新放回收集管中。2. When the gel dissolves, put 4 adsorption columns into the collection tube, add 500ul of equilibrium solution BL to the adsorption column, centrifuge at 12,000 rpm for 1 min, pour out the waste liquid in the collection tube, and put the adsorption column back into the collection tube .

3.将融化好的凝胶溶解降至室温,加入4个吸附柱CA2中(吸附柱放入收集管中),室温放置2min,12,000rpm离心30s,弃废液,将吸附柱CA2放入收集管中。(吸附柱容积为800ul,若样品体积大于800ul可分批加入)3. Dissolve the melted gel to room temperature, add 4 adsorption columns CA2 (the adsorption columns are placed in the collection tube), leave at room temperature for 2 min, centrifuge at 12,000 rpm for 30 s, discard the waste liquid, and put the adsorption column CA2 into the collection tube in the tube. (The volume of the adsorption column is 800ul, if the sample volume is greater than 800ul, it can be added in batches)

4.向吸附柱CA2中加入600ul漂洗液PW(使用前请先检查是否已加入无水乙醇),静置2min,12000rpm离心30sec,倒掉收集管中的废液,1守吸附柱CA2放入收集管中。此步骤重复2次。4. Add 600ul of rinsing solution PW to the adsorption column CA2 (please check whether absolute ethanol has been added before use), let it stand for 2 minutes, centrifuge at 12000rpm for 30sec, pour out the waste liquid in the collection tube, and put it into the adsorption column CA2. in the collection tube. Repeat this step 2 times.

5.将吸附柱12000rpm离心2min,尽量除尽漂洗液。将吸附柱CA2开盖置于室温放置l0min。5. Centrifuge the adsorption column at 12,000 rpm for 2 min to remove as much rinse solution as possible. The adsorption column CA2 was opened and placed at room temperature for 10 min.

6.将吸附柱CA2放到1.5m1低吸附EP管中,向吸附膜中间位置悬空滴加50u1洗脱缓冲液EB,室温放置2min,12000rpm离心2min收集DNA溶液。将离心得到的溶液重新加回离心吸附柱中,室温放置2min,12000rpm离心2min,将DNA溶液收集到离心管中。4个收集管震荡离心,将其中3个收集管中的溶液以低吸附枪头转移到另一个收集管中,震荡30s并瞬时离心,于4℃暂存。6. Put the adsorption column CA2 into a 1.5ml low adsorption EP tube, add 50u1 of elution buffer EB dropwise to the middle of the adsorption membrane, place it at room temperature for 2min, and centrifuge at 12000rpm for 2min to collect the DNA solution. The solution obtained by centrifugation was added back to the centrifugal adsorption column, placed at room temperature for 2 minutes, centrifuged at 12,000 rpm for 2 minutes, and the DNA solution was collected into a centrifuge tube. The 4 collection tubes were shaken and centrifuged, and the solution in 3 collection tubes was transferred to another collection tube with a low adsorption pipette tip, shaken for 30 s, centrifuged briefly, and temporarily stored at 4°C.

2.2.2.5稀释2.2.2.5 Dilution

纯化产物精确定量并稀释至测序所需浓度。The purified product is precisely quantified and diluted to the concentration required for sequencing.

2.2.3高通量测序2.2.3 High-throughput sequencing

2.2.3.1桥式PCR2.2.3.1 Bridge PCR

1.使用NaOH将双链DNA文库变性为单链。1. Denature the double-stranded DNA library to single-stranded using NaOH.

2.将单链DNA模板杂交到Flow Cell上。2. Hybridize the single-stranded DNA template to the Flow Cell.

3.以Flow Cell表面上的oligos为引物合成第一链。3. Synthesize the first strand using oligos on the surface of the Flow Cell as a primer.

4.冲走单链DNA模板,以合成的第一链为模板进行35循环的桥式PCR。4. The single-stranded DNA template was washed away, and a 35-cycle bridge PCR was performed with the synthesized first strand as the template.

5.将与P5接头连接的DNA链从Flow Cell上去除。5. Remove the DNA strand attached to the P5 adapter from the Flow Cell.

6.阻断3'-OH防止在后续测序过程中继续延伸DNA链。6. Blocking the 3'-OH prevents further extension of the DNA strand during subsequent sequencing.

7.杂交测序引物。7. Hybridization sequencing primers.

2.2.3.2测序反应2.2.3.2 Sequencing reaction

1.桥式PCR产物于Illumina X-10测序平台上机测序,操作流程按照标准SOP进行。1. The bridge PCR products were sequenced on the Illumina X-10 sequencing platform, and the operation process was carried out according to the standard SOP.

2.试剂配制,加样上机,进行Read 1测序。2. Reagent preparation, sample loading, and read 1 sequencing.

3.杂交Index测序引物,进行Index测序。3. Hybridize the Index sequencing primers to perform Index sequencing.

4.Paired End Turnround,合成Readl互补链。4.Paired End Turnround, synthesizing Read1 complementary strand.

5.杂交Read 2测序引物,进行Read 2测序。5. Hybridize the Read 2 sequencing primer to perform Read 2 sequencing.

3、数据分析3. Data analysis

3.1多重PCR琼脂糖电泳3.1 Multiplex PCR agarose electrophoresis

如图8和图9所示,3%的琼脂糖凝胶电泳检测,观察PCR产物的效果,确定PC R是否成功。DNALadder从下至上依次为:100,200,300,400,500bp。文库电泳位置于300bp+,质控合格。As shown in Figure 8 and Figure 9, 3% agarose gel electrophoresis was used to detect the effect of PCR products to determine whether the PCR was successful. DNALadder from bottom to top: 100, 200, 300, 400, 500bp. The electrophoresis position of the library is at 300bp+, and the quality control is qualified.

3.2荧光定量PC R质控3.2 Fluorescence quantitative PCR quality control

对2个方案的PCR产物进行定量,以CT值考察每个扩增子的均一度。图10和图11为项目最终优化好的荧光定量PCR结果,二轮产物的总体CT区间在5个CT之内,质控合格。The PCR products of the two schemes were quantified, and the homogeneity of each amplicon was examined by CT value. Figures 10 and 11 show the final optimized fluorescence quantitative PCR results of the project. The overall CT interval of the second-round products is within 5 CTs, and the quality control is qualified.

3.3文库的Agilent 2100质控3.3 Agilent 2100 Quality Control of Libraries

文库纯化后,以Agilent 2100对文库进行质控,主峰位置400bp,质控合格。After the library was purified, the quality control of the library was carried out with Agilent 2100, the main peak position was 400bp, and the quality control was qualified.

3.4测序质控3.4 Sequencing quality control

3.4.1测序数据质控介绍3.4.1 Introduction to Quality Control of Sequencing Data

NGS工作流程包括核酸提取与检测、文库构建与文库检测、上机测序等环节,对这些环节都严格把控,从而保证测序数据的准确性。数据下机后,为了保证后续生物信息学分析结果的准确性,往往需要通过一定的质控方法去除低质量的序列或测序接头。The NGS workflow includes nucleic acid extraction and detection, library construction and library detection, and on-machine sequencing. These links are strictly controlled to ensure the accuracy of sequencing data. After the data is downloaded, in order to ensure the accuracy of subsequent bioinformatics analysis results, it is often necessary to remove low-quality sequences or sequencing adapters through certain quality control methods.

3.4.2原始测序数据3.4.2 Raw sequencing data

测序得到的原始二进制basecal I ing数据经Illuminabcl2fastq软件转化为序列数据,本发明称之为PF data或Raw data,结果以fastq文件格式存储(文件名:*.fastq.gz),fastq文件为用户得到的最原始文件,里面存储reads的序列以及reads的测序质量。在fastq格式文件中每个read由四行描述:The original binary basecal ing data obtained by sequencing is converted into sequence data by Illuminabcl2fastq software, which is called PF data or Raw data in the present invention, and the result is stored in the fastq file format (file name: *.fastq.gz), and the fastq file is obtained by the user The most original file, which stores the sequence of reads and the sequencing quality of reads. Each read in the fastq format file is described by four lines:

@E00477:71:H7YJWALXX:7:1101:12236:18011:N:O:CGAGGCTG@E00477:71:H7YJWALXX:7:1101:12236:18011:N:O:CGAGGCTG

GATCATTACTATATTTTGCTACGGTTGAGAGAAACGAATGCCCCTGTAACGATCATTACTATATTTTGCTACGGTTGAGAGAAACGAATGCCCCTGTAAC

++

AAFFFAKKKKKKKKKKKKKKKKKKFFFKKKKKKKKKKKKKKKAAFKKKKKAAFFFAKKKKKKKKKKKKKKKKKKFFFKKKKKKKKKKKKKKKAAFKKKKK

第1行是序列名称,由测序仪产生,包含index序列及readl或read2标志;The first line is the sequence name, generated by the sequencer, including the index sequence and the read1 or read2 flag;

第2行是序列;由大写“ACGTN”组成;Line 2 is the sequence; consists of uppercase "ACGTN";

第3行是序列ID,也有省略了ID名称后直接用”+“表示;The third line is the sequence ID, and it is also directly represented by "+" after omitting the ID name;

第4行是序列的测序质量,每个字母对应第2行每个碱基。Row 4 is the sequencing quality of the sequence, with each letter corresponding to each base in row 2.

其中,ASCII码质量值与十进制的质量值之间的换算关系如下所示:Among them, the conversion relationship between the ASCII code quality value and the decimal quality value is as follows:

Qscore=ASCII value-33Qscore=ASCII value-33

例如:@对应的ASCII值是64,那么其对应的碱基质量值是31(64-33)。从IlluminaGAPipeline v1.8开始,测序碱基质量值的范围是[0,41],即ASCII值表示为[#,K]。Illumina测序错误率与测序质量值简明对应关系。具体地,如果测序错误率用E表示,Illumina碱基质量值用Q表示,关系如下:Q=-10log10(E)。For example: the ASCII value corresponding to @ is 64, then the corresponding base quality value is 31 (64-33). Starting from IlluminaGAPipeline v1.8, the range of sequencing base quality values is [0,41], that is, the ASCII value is expressed as [#,K]. Concise correspondence between Illumina sequencing error rates and sequencing quality values. Specifically, if the sequencing error rate is represented by E, and the Illumina base quality value is represented by Q, the relationship is as follows: Q=-10log10(E).

3.4.3测序数据产量统计3.4.3 Sequencing data yield statistics

Illumina RTA软件进行图像识别和Basecalling,Illuminabcl2fastq 2.17根据每个样本的index信息进行demultiplexing并统计产出reads数和碱基测序质量(Q30)。Illumina RTA software performs image recognition and basecalling, and Illuminabcl2fastq 2.17 performs demultiplexing according to the index information of each sample and counts the number of reads and base sequencing quality (Q30).

表19测序样本数据产出统计表(展示部分)Table 19 Sequencing sample data output statistics table (display part)

Figure BDA0002416206000000171
Figure BDA0002416206000000171

注:Note:

(1)Sample:样本名称;(1) Sample: sample name;

(2)Raw reads:统计原始数据双端Readpair总数目(Reads总数);(2) Raw reads: Count the total number of double-ended Readpairs of raw data (total number of Reads);

(3)Raw data(bp):原始数据产量,测序序列的个数乘以测序序列的长度,以by为单位;(3) Raw data (bp): raw data yield, the number of sequenced sequences multiplied by the length of the sequenced sequence, in by;

(4)Q30(%):计算Phred数值大于30的碱基占总体碱基的百分比,Read1和Read2一起统计的平均值;(4) Q30 (%): Calculate the percentage of bases with Phred values greater than 30 in the total bases, and the average value of Read1 and Read2 statistics together;

(5)Clean reads:统计有效序列双端Readpair总数目(Reads总数);(5) Clean reads: Count the total number of double-ended Readpairs of valid sequences (total number of Reads);

(6)Clean data(bp):过滤之后的有效数据量,过滤后测序序列的个数乘以测序序列的长度,以by为单位。(6) Clean data (bp): The amount of valid data after filtering, the number of sequenced sequences after filtering is multiplied by the length of the sequenced sequence, in by.

以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent replacements and improvements made within the spirit and principles of the present invention shall be included in the protection of the present invention. within the range.

Claims (10)

1.一种多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法PCR扩增时,引物的3`端碱基跟模板完全匹配时,DNA聚合酶进行延伸反应,检测信号就强;如果引物的3`端碱基跟模板不匹配,检测信号就弱;根据等位基因的基因型的不同设计不同的引物,将不同的等位基因区分开,在不同等位基因的引物5端各自连上一段不同的tag序列,序列能与芯片上点制的tag序列杂交,实现对基因型的判读。1. a multiplex PCR_SNP genotyping detection method, is characterized in that, during described multiplex PCR_SNP genotyping detection method PCR amplification, when the 3' end base of primer is fully matched with template, DNA polymerase carries out extension reaction, The detection signal is strong; if the base at the 3' end of the primer does not match the template, the detection signal is weak; different primers are designed according to the different genotypes of the alleles to distinguish different alleles. The 5 ends of the primers of the gene are respectively connected with a different tag sequence, and the sequence can hybridize with the tag sequence ordered on the chip to realize the interpretation of the genotype. 2.如权利要求1所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法的四个SNP位点设计引物,并在上游引物的5`端分别连接Tag1/Tag2、Tag3/Tag4、Tag5/Tag6、Tag7/Tag8,同时用这四对Tag点制芯片,每个Tag重复点3个点,同时点上杂交阳性质控点PC 3个,杂交阴性质控点NC 3个,Blank点3个,Hex点3个。2. multiple PCR_SNP genotyping detection method as claimed in claim 1, is characterized in that, four SNP site design primers of described multiple PCR_SNP genotyping detection method, and connect Tag1 respectively at the 5' end of upstream primer /Tag2, Tag3/Tag4, Tag5/Tag6, Tag7/Tag8, use these four pairs of Tag to make chips at the same time, each Tag repeats 3 spots, and simultaneously spot 3 hybridization positive quality control points PC, hybridization negative quality control 3 for NC, 3 for Blank, and 3 for Hex. 3.如权利要求1所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括设计待测SNP位点的PCR扩增引物及单碱基延伸引物。3 . The multiplex PCR_SNP genotyping detection method according to claim 1 , wherein the multiplex PCR_SNP genotyping detection method comprises designing PCR amplification primers and single-base extension primers of the SNP sites to be detected. 4 . 4.如权利要求3所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括提取血样中的DNA,用分光光度计定量,琼脂糖凝胶电泳质检,质检合格的DNA将浓度调整到50ηg/ul,-20℃储存备用。4. multiplex PCR_SNP genotyping detection method as claimed in claim 3, is characterized in that, described multiplex PCR_SNP genotyping detection method comprises extracting DNA in blood sample, quantifying with spectrophotometer, agarose gel electrophoresis quality inspection , the concentration of DNA that has passed the quality inspection is adjusted to 50ηg/ul, and stored at -20°C for later use. 5.如权利要求4所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括PCR扩增,采用多重PCR扩增技术,每个反应总体积5ul,包含模板DNA10ηg,HotstarTaq 0.5U,扩增引物每条0.5pmol,25mM dNTP,0.1ul,反应条件为94℃4分钟;94℃20秒,56℃30秒,72℃1分钟,45个循环;72℃3分钟;4℃。5. multiple PCR_SNP genotyping detection method as claimed in claim 4 is characterized in that, described multiple PCR_SNP genotyping detection method comprises PCR amplification, adopts multiple PCR amplification technology, and each reaction total volume 5ul, comprises Template DNA 10ng, HotstarTaq 0.5U, each amplification primer 0.5pmol, 25mM dNTP, 0.1ul, the reaction conditions are 94°C for 4 minutes; 94°C for 20 seconds, 56°C for 30 seconds, 72°C for 1 minute, 45 cycles; 72°C 3 minutes; 4°C. 6.如权利要求5所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括PCR产物纯化,PCR反应产物使用0.5U SAP处理,去除体系中游离的dNTP,反应体系7μl,其中PCR产物5μl,SAP混合液2μl,SAP 0.5U,buffer 0.17μl,反应程序37℃20分钟;85℃5分钟;4℃。6. multiple PCR_SNP genotyping detection method as claimed in claim 5, is characterized in that, described multiple PCR_SNP genotyping detection method comprises PCR product purification, and PCR reaction product uses 0.5U SAP to process, removes free dNTP in the system , the reaction system is 7 μl, including 5 μl of PCR product, 2 μl of SAP mixture, 0.5 U of SAP, 0.17 μl of buffer, and the reaction program is 37°C for 20 minutes; 85°C for 5 minutes; 4°C. 7.如权利要求6所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括单碱基延伸,总体积9μl反应体系包含SAP处理后PCR产物7μl,其中各延伸反应引物混合物0.804l,iPLEX酶0.041l,延伸混合物0.2μl,反应程序为94℃30秒;94℃5秒;52℃5秒,80℃5秒5个循环;返回94℃5秒,共40个循环;72℃3分钟,4℃。7. The multiplex PCR_SNP genotyping detection method as claimed in claim 6, wherein the multiplex PCR_SNP genotyping detection method comprises single base extension, and the total volume 9 μl reaction system comprises 7 μl of the PCR product after SAP treatment, wherein Each extension reaction primer mix 0.804l, iPLEX enzyme 0.041l, extension mix 0.2μl, the reaction program is 94°C for 30 seconds; 94°C for 5 seconds; 52°C for 5 seconds, 80°C for 5 seconds for 5 cycles; return to 94°C for 5 seconds, A total of 40 cycles; 3 min at 72°C, 4°C. 8.如权利要求7所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括树脂纯化,每个延伸反应产物用6mg Clean Resin树脂纯化;8. multiple PCR_SNP genotyping detection method as claimed in claim 7 is characterized in that, described multiple PCR_SNP genotyping detection method comprises resin purification, and each extension reaction product is purified with 6mg Clean Resin resin; 芯片点样及质谱检测,将纯化产物移至384孔SpectroCHIP芯片上,上机测定,SpectroCHIP芯片使用MALDI-TOF基质辅助激光解吸附电离飞行时间质谱分析,检测结果使用软件分型并输出结果。Chip spotting and mass spectrometry detection, the purified product was transferred to a 384-well SpectroCHIP chip, and measured on the computer. The SpectroCHIP chip was analyzed by MALDI-TOF matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and the detection results were typed and output by software. 9.如权利要求8所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括:9. multiple PCR_SNP genotyping detection method as claimed in claim 8, is characterized in that, described multiple PCR_SNP genotyping detection method comprises: (1)数据预处理,过滤掉在所有样品中无信息量的位点及分型成功率小于90%的位点;过滤掉在对照样品中MAF小于0.01的位点;用对照样品,对每个SNP位点进行哈迪-温伯格平衡检验;(1) Data preprocessing, filtering out non-informative sites in all samples and sites with typing success rate less than 90%; filtering out sites with MAF less than 0.01 in control samples; using control samples, for each Hardy-Weinberg equilibrium test for each SNP site; (2)单点关联分析方法,针对预处理后的每个位点,用卡方检验和Fisher精确检验方法对四种情况检验病例和对照间的差异,并对能计算比值比的情况,计算比值比及其95%置信区间。(2) Single-point association analysis method, for each locus after preprocessing, the chi-square test and Fisher's exact test were used to test the differences between the cases and controls for the four cases, and for the cases where the odds ratio could be calculated, calculate Odds ratios and their 95% confidence intervals. 10.如权利要求9所述的多重PCR_SNP基因分型检测方法,其特征在于,所述多重PCR_SNP基因分型检测方法包括四种情况:10. multiple PCR_SNP genotyping detection method as claimed in claim 9, is characterized in that, described multiple PCR_SNP genotyping detection method comprises four kinds of situations: (1)对等位基因频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间;(1) Perform chi-square test and Fisher exact test on allele frequencies and calculate OR value and 95% confidence interval; (2)对基因型频率进行卡方检验和Fisher精确检验;(2) Chi-square test and Fisher's exact test for genotype frequencies; (3)针对显性模型对基因型频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间;(3) Chi-square test and Fisher's exact test were performed on the genotype frequencies for the dominant model, and the OR value and 95% confidence interval were calculated; (4)针对隐性模型对基因型频率进行卡方检验和Fisher精确检验并计算OR值及95%置信区间。(4) Chi-square test and Fisher's exact test were performed on the genotype frequencies for the recessive model, and the OR value and 95% confidence interval were calculated.
CN202010191848.2A 2020-03-18 2020-03-18 Multiple PCR _ SNP genotyping detection method Pending CN111235239A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010191848.2A CN111235239A (en) 2020-03-18 2020-03-18 Multiple PCR _ SNP genotyping detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010191848.2A CN111235239A (en) 2020-03-18 2020-03-18 Multiple PCR _ SNP genotyping detection method

Publications (1)

Publication Number Publication Date
CN111235239A true CN111235239A (en) 2020-06-05

Family

ID=70872079

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010191848.2A Pending CN111235239A (en) 2020-03-18 2020-03-18 Multiple PCR _ SNP genotyping detection method

Country Status (1)

Country Link
CN (1) CN111235239A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112980946A (en) * 2021-04-28 2021-06-18 华中科技大学同济医学院附属协和医院 Gene polymorphism detection kit and detection method for guiding administration of rocuronium bromide serving as skeletal muscle relaxant
CN113151449A (en) * 2021-05-18 2021-07-23 华中科技大学同济医学院附属协和医院 Gene polymorphism detection kit and detection method for guiding administration of sevoflurane serving as inhalation anesthetic

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096277A1 (en) * 2001-08-30 2003-05-22 Xiangning Chen Allele specific PCR for genotyping
WO2008106987A1 (en) * 2007-03-06 2008-09-12 Eesti Biokeskus A method to determine single nucleotide polymorphisms and mutations in nucleic acid sequence
CN102399900A (en) * 2011-12-16 2012-04-04 上海天昊生物科技有限公司 Gene polymorphism detection method and kit
CN105238853A (en) * 2015-08-20 2016-01-13 复旦大学附属华山医院 Method for simultaneously measuring gene polymorphism of tacrolimus action targets of person
CN107075565A (en) * 2014-11-21 2017-08-18 深圳华大基因研究院 Individual mononucleotide polymorphism site classifying method and device
CN107974489A (en) * 2017-11-20 2018-05-01 江苏美因康生物科技有限公司 A kind of method for detecting people's HLA-B*5801 allele
CN110172502A (en) * 2019-03-25 2019-08-27 为康(苏州)基因科技有限公司 A kind of detection method and detection kit of hpa gene parting

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096277A1 (en) * 2001-08-30 2003-05-22 Xiangning Chen Allele specific PCR for genotyping
WO2008106987A1 (en) * 2007-03-06 2008-09-12 Eesti Biokeskus A method to determine single nucleotide polymorphisms and mutations in nucleic acid sequence
US20090048119A1 (en) * 2007-03-06 2009-02-19 Estonian Bioncenter Method to determine single nucleotide polymorphisms and mutations in nucleic acid sequence
CN102399900A (en) * 2011-12-16 2012-04-04 上海天昊生物科技有限公司 Gene polymorphism detection method and kit
CN107075565A (en) * 2014-11-21 2017-08-18 深圳华大基因研究院 Individual mononucleotide polymorphism site classifying method and device
CN105238853A (en) * 2015-08-20 2016-01-13 复旦大学附属华山医院 Method for simultaneously measuring gene polymorphism of tacrolimus action targets of person
CN107974489A (en) * 2017-11-20 2018-05-01 江苏美因康生物科技有限公司 A kind of method for detecting people's HLA-B*5801 allele
CN110172502A (en) * 2019-03-25 2019-08-27 为康(苏州)基因科技有限公司 A kind of detection method and detection kit of hpa gene parting

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
张艳等: "应用基因芯片技术检测非综合征型耳聋基因突变", 生物技术通讯, vol. 21, no. 1, pages 22 - 26 *
张阳东;温新宇;董矜;楚瑞雪;田亚平;: "冠心病相关基因多重单核苷酸多态性分型检测法的构建", no. 09, pages 1 - 5 *
程鹏: "Tag Array结核耐药基因检测芯片快速诊断一、二线药物耐药的可行性研究", 中国优秀硕士学位论文全文数据库 医药卫生科技辑, pages 061 - 27 *
赵云坡;张浩;杨晓楠;詹帅;黄勇平;苗雪霞;: "采用单碱基延伸法检测家蚕单核苷酸多态性位点", no. 03, pages 69 - 73 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112980946A (en) * 2021-04-28 2021-06-18 华中科技大学同济医学院附属协和医院 Gene polymorphism detection kit and detection method for guiding administration of rocuronium bromide serving as skeletal muscle relaxant
CN113151449A (en) * 2021-05-18 2021-07-23 华中科技大学同济医学院附属协和医院 Gene polymorphism detection kit and detection method for guiding administration of sevoflurane serving as inhalation anesthetic

Similar Documents

Publication Publication Date Title
US12227804B2 (en) Determining a nucleic acid sequence imbalance associated with cancer using multiple markers
Turchi et al. Evaluation of a microhaplotypes panel for forensic genetics using massive parallel sequencing technology
US7879543B2 (en) Method of detecting mutations associated with thrombosis
CN112080554B (en) Design method of primer and probe for detecting dense mononucleotide variation sites by MALDI-TOF mass spectrum
CN116463410A (en) Gene detector for accurate hypertension medication based on Massarray nucleic acid mass spectrometry technology and application thereof
CN111944912A (en) Skin gene detection method
CN111235239A (en) Multiple PCR _ SNP genotyping detection method
CN114150051A (en) Integrated kit and method for comprehensively detecting five complex genetic diseases
CN104988223A (en) Primer and method for simultaneously detecting VKORC1 and CYP2C9 gene polymorphisms
CN115725745B (en) SNP molecular marker related to sheep multi-thoracic vertebrae and amplification primer set and application
Shi et al. Application of kinetic polymerase chain reaction and molecular beacon assays to pooled analyses and high‐throughput genotyping for candidate genes
CN112592972B (en) Early screening method and kit for diffuse toxic goiter susceptibility genes
CN116218984A (en) Nucleic acid combination, kit and detection method for detecting antidepressant drug genes based on time-of-flight nucleic acid mass spectrometry technology
CN113025702A (en) Early screening method and kit for ankylosing spondylitis susceptibility genes
CN110734970A (en) auto-inflammatory monogenic disease detection primer group and method
Amr et al. Targeted hybrid capture for inherited disease panels
CN117551765A (en) A method to simultaneously detect multiple HLA SNPs related to HCC risk after HBV infection
AU2017236002B2 (en) Analyzing tumor dna in a cell- free sample
JP4677646B2 (en) Apolipoprotein E gene polymorphism detection method, genotype determination method and reagent for apolipoprotein E gene polymorphism
CN121380368A (en) A liquid-phase chip for detecting porcine genetic stability and its application
HK40084567A (en) Determining a nucleic acid sequence imbalance
CN119020487A (en) A primer-probe combination, kit and detection method for detecting gene polymorphism of hypertension medication
HK40050107A (en) Determining a nucleic acid sequence imbalance
CN111321223A (en) Primer and probe for detecting pancreatic cancer related site polymorphism based on multiple PCR flight nucleic acid mass spectrometry technology and application of primer and probe
HK40035291A (en) Determining a fetal aneuploidy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200605